期刊
JOURNAL OF IMMUNOLOGY
卷 183, 期 9, 页码 6013-6020出版社
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.0902038
关键词
-
类别
资金
- Italian Ministry of University and Scientific and Technologic Research
- Agenzia Italiana del Farmaco [FARM7SJX]
- National Institutes of Health [060866, HL67211]
- Associazione Indiana per la Ricerca sul Cancro, Milan, Italy
Mixed cryoglobulinemia (MC) is a lymphoproliferative disorder observed in similar to 10 to 15% of hepatitis C virus (HCV)-infected patients. Circulating, nonenveloped HCV core protein, which has been detected in cryoprecipitable immune complexes, interacts with immunocytes through the receptor for the globular domain of C1q protein (gC1q-R). In this study, we have evaluated circulating gC1q-R levels in chronically HCV-infected patients, with and without MC. These levels were significantly higher in MC patients than in those without MC and in healthy controls and paralleled specific mRNA expression in PBL. Soluble gC1q-R circulates as a complexed form containing both C1q and HCV core proteins. Higher serum gC1q-R levels negatively correlated with circulating concentrations of the C4d fragment. The presence of sequestered C4d in the vascular bed of skin biopsies from MC patients was indicative of in situ complement activation. In vitro studies showed that release of soluble gC1q-R is regulated by HCV core-mediated inhibition of cell proliferation. Our results indicate that up-regulation of gC1q-R expression is a distinctive feature of MC, and that dysregulated shedding of C1q-R molecules contributes to vascular cryoglobulin-induced damage via the classic complement-mediated pathway. The Journal of Immunology, 2009, 183: 6013-6020.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据